Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor

Journal of Biological Chemistry

Volumn 287, Issue 52, 2012, Pages 43565-43572

  Garnier, Delphine ^a   Magnus, Nathalie ^a   Lee, Tae Hoon ^a   Bentley, Victoria ^a   Meehan, Brian ^a   Milsom, Chloe ^b   Montermini, Laura ^a   Kislinger, Thomas ^c   Rak, Janusz ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL MEMBRANES; DISEASES; ENDOTHELIAL CELLS; TISSUE;

BIOACTIVE MOLECULES; EPIDERMAL GROWTH FACTOR RECEPTORS; EPITHELIAL CANCER CELLS; EPITHELIAL TO MESENCHYMAL TRANSITIONS; HETEROGENEOUS MEMBRANES; MICRO-PARTICLES; TISSUE FACTORS; VASCULAR SYSTEM;

CYTOLOGY;

EPIDERMAL GROWTH FACTOR RECEPTOR; THROMBOPLASTIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL INTERACTION; CELL MEMBRANE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXOSOME; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 84871602943     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.401760     Document Type: Article

References (45)

1. Rak, J. (2009) Ras oncogenes and tumour vascular interface in Cancer Genome and Tumor Microenvironment (Thomas-Tikhonenko, A., ed) pp. 150-170, Springer, New York
2. Carmeliet, P., and Jain, R. K. (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307
3. Ruf, W., Disse, J., Carneiro-Lobo, T. C., Yokota, N., and Schaffner, F. (2011) Tissue factor and cell signalling in cancer progression and thrombosis. J. Thromb. Haemost. 9, 306-315
4. Milsom, C. C., Yu, J. L., Mackman, N., Micallef, J., Anderson, G. M., Guha, A., and Rak, J. W. (2008) Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res. 68, 10068-10076
5. Rong, Y., Belozerov, V. E., Tucker-Burden, C., Chen, G., Durden, D. L., Olson, J. J., Van Meir, E. G., Mackman, N., and Brat, D. J. (2009) Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res. 69, 2540-2549
6. Magnus, N., Garnier, D., and Rak, J. (2010) Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. Blood 116, 815-818
7. Rickles, F. R. (2006) Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol. Haemost. Thromb. 35, 103-110
8. Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., and Ruf, W. (2008) Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190-199
9. Falanga, A. (2005) Thrombophilia in cancer. Semin. Thromb. Hemost. 31, 104-110
10. Rak, J., and Guha, A. (2012) Extracellular vesicles-vehicles that spread cancer genes. Bioessays 34, 489-497
11. Al-Nedawi, K., Meehan, B., and Rak, J. (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8, 2014-2018
12. Del Conde, I., Shrimpton, C. N., Thiagarajan, P., and López, J. A. (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604-1611 (Pubitemid 41208572)
13. Théry, C., Ostrowski, M., and Segura, E. (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593
14. Zwicker, J. I. (2010) Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb. Res. 125, S89-S91
15. Lacroix, R., Judicone, C., Poncelet, P., Robert, S., Arnaud, L., Sampol, J., and Dignat-George, F. (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J. Thromb. Haemost. 10, 437-446
16. Citri, A., and Yarden, Y. (2006) EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7, 505-516 (Pubitemid 44036456)
17. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., and Rak, J. (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624 (Pubitemid 351627382)
18. Di Vizio, D., Kim, J., Hager, M. H., Morello, M., Yang, W., Lafargue, C. J., True, L. D., Rubin, M. A., Adam, R. M., Beroukhim, R., Demichelis, F., and Freeman, M. R. (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 69, 5601-5609
19. Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., and D'Souza-Schorey, C. (2010) Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611
20. Zwicker, J. I., Trenor, C. C., 3rd, Furie, B. C., and Furie, B. (2011) Tissue factor-bearing microparticles and thrombus formation. Arterioscler. Thromb. Vasc. Biol. 31, 728-733
21. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B. A., Callahan, M. K., Yuan, J., Martins, V. R., Skog, J., Kaplan, R. N., Brady, M. S., Wolchok, J. D., Chapman, P. B., Kang, Y., Bromberg, J., and Lyden, D. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET. Nat. Med. 18, 883-891
22. Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., Curry, W. T., Jr., Carter, B. S., Krichevsky, A. M., and Breakefield, X. O. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476
23. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S., and Zitvogel, L. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303 (Pubitemid 32224344)
24. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell. 139, 871-890
25. Scheel, C., Eaton, E. N., Li, S. H., Chaffer, C. L., Reinhardt, F., Kah, K. J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., and Weinberg, R. A. (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 145, 926-940
26. Yu, J., May, L., Milsom, C., Anderson, G. M., Weitz, J. I., Luyendyk, J. P., Broze, G., Mackman, N., and Rak, J. (2008) Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler. Thromb. Vasc. Biol. 28, 1975-1981
27. Yu, J. L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J. I., Coomber, B. L., Mackman, N., and Rak, J. W. (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105, 1734-1741 (Pubitemid 40223697)
28. Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C., and Rak, J. (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. U.S.A. 106, 3794-3799
29. Dragovic, R. A., Gardiner, C., Brooks, A. S., Tannetta, D. S., Ferguson, D. J., Hole, P., Carr, B., Redman, C. W., Harris, A. L., Dobson, P. J., Harrison, P., and Sargent, I. L. (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7, 780-788
30. Taylor, P., Nielsen, P. A., Trelle, M. B., Hørning, O. B., Andersen, M. B., Vorm, O., Moran, M. F., and Kislinger, T. (2009) Automated 2D peptide separation on a 1D nano-LC-MS system. J. Proteome Res. 8, 1610-1616
31. Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., Matteoli, M., and Verderio, C. (2009) Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28, 1043-1054
32. Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., and Nemerson, Y. (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat. Med. 9, 458-462 (Pubitemid 36460081)
33. Hansen, C. B., Pyke, C., Petersen, L. C., and Rao, L. V. (2001) Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 97, 1712-1720 (Pubitemid 32217238)
34. St Croix, B., Sheehan, C., Rak, J. W., Flørenes, V. A., Slingerland, J. M., and Kerbel, R. S. (1998) E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell Biol. 142, 557-571 (Pubitemid 28361560)
35. Heuberger, J., and Birchmeier, W. (2010) Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol. 2, a002915
36. Mandal, S. K., Pendurthi, U. R., and Rao, L. V. (2007) Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood 110, 161-170 (Pubitemid 47026831)
37. Mandal, S. K., Pendurthi, U. R., and Rao, L. V. (2006) Cellular localization and trafficking of tissue factor. Blood 107, 4746-4753 (Pubitemid 43882625)
38. Davila, M., Amirkhosravi, A., Coll, E., Desai, H., Robles, L., Colon, J., Baker, C. H., and Francis, J. L. (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J. Thromb. Haemost. 6, 1517-1524
39. Wang, J. G., Geddings, J. E., Aleman, M. M., Cardenas, J. C., Chantrathammachart, P., Williams, J. C., Kirchhofer, D., Bogdanov, V. Y., Bach, R. R., Rak, J., Church, F. C., Wolberg, A. S., Pawlinski, R., Key, N. S., Yeh, J. J., and Mackman, N. (2012) Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 119, 5543-5552
40. Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., Alexe, G., Lawrence, M., O'Kelly, M., Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L., Feiler, H. S., Hodgson, J. G., James, C. D., Sarkaria, J. N., Brennan, C., Kahn, A., Spellman, P. T., Wilson, R. K., Speed, T. P., Gray, J. W., Meyerson, M., Getz, G., Perou, C. M., and Hayes, D. N. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110
41. van Hinsbergh, V. (2012) Endothelium-role in regulation of coagulation and inflammation. Semin. Immunopathol. 34, 93-106
42. Contrino, J., Hair, G., Kreutzer, D. L., and Rickles, F. R. (1996) In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat. Med. 2, 209-215 (Pubitemid 26054985)
43. Horowitz, N. A., Blevins, E. A., Miller, W. M., Perry, A. R., Talmage, K. E., Mullins, E. S., Flick, M. J., Queiroz, K. C., Shi, K., Spek, C. A., Conway, E. M., Monia, B. P., Weiler, H., Degen, J. L., and Palumbo, J. S. (2011) Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood. 118, 2889-2895
44. Zuo, J. H., Zhu, W., Li, M. Y., Li, X. H., Yi, H., Zeng, G. Q., Wan, X. X., He, Q. Y., Li, J. H., Qu, J. Q., Chen, Y., and Xiao, Z. Q. (2011) Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and matrix metalloproteinase 9-mediated degradation of E-cadherin. J. Cell. Biochem. 112, 2508-2517
45. Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., Stack, M. S., and Hudson, L. G. (2008) Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res. 68, 4606-4613